| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2001 | WO2001052816A3 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001051073A3 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 12/20/2001 | WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 12/20/2001 | WO2001047511A3 Treatment of drug-resistant human immunodeficiency virus infection |
| 12/20/2001 | WO2001044295A3 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 12/20/2001 | WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001041705A3 Novel methods for the treatment and prevention of dizziness and pruritus |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | WO2001039745A3 Aerosol composition comprising formoterol |
| 12/20/2001 | WO2001035937A3 Lipid complex of alkycyclines |
| 12/20/2001 | WO2001034120B1 Apparatus and method for preparing microparticles using in-line solvent extraction |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001030391A3 Pharmaceutical composition containing midazolam |
| 12/20/2001 | WO2001022969A3 Vasopressin agonist formulation and process |
| 12/20/2001 | WO2001019770A3 Rxr modulators with improved pharmacologic profile |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | WO2001015693A3 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 12/20/2001 | WO2001013949A3 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 12/20/2001 | WO2001010426A3 Use of ep4 receptor ligands in the treatment of neuropathic pain and colon cancer |
| 12/20/2001 | WO2001007047A3 Control of crustacean infestation of aquatic animals |
| 12/20/2001 | WO2001000194A3 A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions |
| 12/20/2001 | WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 12/20/2001 | WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts |
| 12/20/2001 | WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation |
| 12/20/2001 | WO1999063976A3 Liver-selective glucocorticoid antagonist for treating diabetes |
| 12/20/2001 | WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 12/20/2001 | WO1999016429A3 Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
| 12/20/2001 | WO1997049394A3 Sold oral dosage forms of valsartan |
| 12/20/2001 | US20010053853 Alkanoic acid derivative; integrin receptor antagonist |
| 12/20/2001 | US20010053851 Antidiabetic agents |
| 12/20/2001 | US20010053845 Anthracycline analogues bearing latent alkylating substituents |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053800 Long chain monounsaturated alcohol mixtures |
| 12/20/2001 | US20010053799 New treatments using venlafaxine |
| 12/20/2001 | US20010053798 S(+) desmethylselegiline and drug withdrawal |
| 12/20/2001 | US20010053797 Modulation of n-methyl-d-aspartate receptor responses with s-substituted derivatives of glutathione |
| 12/20/2001 | US20010053796 Culture of fish in water tank |
| 12/20/2001 | US20010053795 Hypotensive agents |
| 12/20/2001 | US20010053794 Ionic polymers as anti-infective agents |
| 12/20/2001 | US20010053793 Administering dehydroascorbic acid |
| 12/20/2001 | US20010053792 Epicatechin |
| 12/20/2001 | US20010053791 Glycogen phosphorylase inhibitor |
| 12/20/2001 | US20010053790 Mothod and composition for treatment of ischemic neuronal reperfusion injury |
| 12/20/2001 | US20010053788 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity |
| 12/20/2001 | US20010053787 Compositions for treating alergic and other disorders using norastemizole in combination with other active ingredients |
| 12/20/2001 | US20010053786 Methods for treating addictive disorders |
| 12/20/2001 | US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 12/20/2001 | US20010053783 Central nervous system disorders |
| 12/20/2001 | US20010053782 Pyrrolo[2,3-d]pyrimidine compounds |
| 12/20/2001 | US20010053781 Mixture of ferulic acid in carrier |
| 12/20/2001 | US20010053780 Medical article; therapy for sexual disorders |
| 12/20/2001 | US20010053778 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/20/2001 | US20010053777 Synergistic mixture containing alpha 2-antagonist agent and neuropsychic drug |
| 12/20/2001 | US20010053774 Non-steroidal ligands for the estrogen receptor |
| 12/20/2001 | US20010053773 Administering a chemotherapeutic agent such as taxol or cisplatin and a benzimidazole such as 2-methoxycarbonylaminobenzimidazole |
| 12/20/2001 | US20010053772 Regulating cytokine activity by administering a glycerol derivative, such as phosphoric acid, (2-trimethylammonium ethyl) (2-alkoxypropyl-3-alkylaminopropyl) ester |
| 12/20/2001 | US20010053771 Topical |
| 12/20/2001 | US20010053763 Method and composition for modulating an immune response |
| 12/20/2001 | US20010053760 Treatment of infarcts |
| 12/20/2001 | US20010053758 Methods and compositions for the treatment and prevention of lung disease |
| 12/20/2001 | US20010053388 Containing a bisphosphonate acid or its pharmaceutically acceptable salt dissolved in an aqueous solution, and a polymeric gel forming agent capable of inhibiting diffusion of the active ingredient with human tissue. |
| 12/20/2001 | US20010053387 Benzimidazole pharmaceutical composition and process of prepatation |
| 12/20/2001 | US20010053386 (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one maleate |
| 12/20/2001 | US20010053379 Administering Linalool alone or along with Vitamin E and/or other hypoglycemic agents. |
| 12/20/2001 | US20010053373 Combining a solid dosage form and aqueous diluent in a single-use mixing and dosing cup having an abrasive interior surface and mixing to form a liquid dosage formulation. |
| 12/20/2001 | US20010053356 Garlic ingredients and antioxidants in the prevention and treatment of vascular-related disorders and pathological angiogenesis-mediated disorders |
| 12/20/2001 | US20010053351 Inhibition of GSK-3 beta |
| 12/20/2001 | US20010053350 Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives |
| 12/20/2001 | US20010053347 Methods and compositions for preventing and treating chronological aging in human skin |
| 12/20/2001 | DE10128250A1 New hydrolytically stable glycolipid compounds having an alpha-C, N or S glycoside bond, useful as anticancer agents and immunostimulants |
| 12/20/2001 | DE10037272A1 Identifying agents for treating cardiovascular disease, comprises determining the ability of potential agents to modify interaction between beta3 endonexin and beta3 integrin |
| 12/20/2001 | DE10029770A1 Treatment of solid tumors, especially brain tumors, using curcumin or derivative to inhibit peritumoral edema and tumor growth and kill the tumor cells |
| 12/20/2001 | DE10029047A1 Treating or preventing intrahepatic cholestasis and regulating cholesterol formation, using luteolin-7-O-glucuronide to combat intrahepatic changes in the bile ducts |
| 12/20/2001 | DE10029014A1 Urokinase inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative |
| 12/20/2001 | DE10028638A1 Storage-stable composition useful in cosmetic and pharmaceutical compositions comprises combination of glycerol monoalkyl ether with antioxidant |
| 12/20/2001 | DE10026666A1 Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen Use of hyaluronidase for the prophylaxis and treatment of cardiovascular diseases |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | CA2436116A1 Treatment and prevention of cardiac insulin resistance associated conditions |
| 12/20/2001 | CA2416796A1 Radioprotective agents |
| 12/20/2001 | CA2415369A1 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity |
| 12/20/2001 | CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/20/2001 | CA2412843A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy |
| 12/20/2001 | CA2412842A1 Combination product for carrying out a cytotoxic treatment in a mammal |
| 12/20/2001 | CA2412632A1 Hmg-coa reductase inhibitors and method |
| 12/20/2001 | CA2412623A1 Tetrapyrroles |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412462A1 6,5-fused bicyclic heterocycles |
| 12/20/2001 | CA2412435A1 Phytonutrient formula for the relief of chronic pain resulting from inflammation |
| 12/20/2001 | CA2412355A1 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 12/20/2001 | CA2412353A1 Protease inhibitors |
| 12/20/2001 | CA2412327A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/20/2001 | CA2412316A1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2412216A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | CA2412165A1 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 12/20/2001 | CA2412010A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 12/20/2001 | CA2411813A1 Tricyclic compounds as mrp1-inhibitors |